Keeping track of all ongoing colorectal cancer trials using a mobile application: Usability and satisfaction results of the Dutch Colorectal Cancer Group Trials application
Journal Title: Journal of Clinical and Translational Research - Year 2018, Vol 3, Issue 3
Abstract
Background and Aim: Both the number and complexity of medical trials are increasing vastly. To facilitate easy access to concise trial information, a freely available mobile application including all ongoing clinical trials of the Dutch Colorectal Cancer Group (DCCG) was developed. The aim of this study was to investigate the use and user satisfaction over the first 2 years. Methods: The application was launched in January 2015 on iOS and Android platforms. Google Analytics was used to monitor anonymous user data up to February 2017. In addition, an online survey regarding the use and satisfaction among health-care professionals and research affiliates active in the field of colorectal cancer in the Netherlands was conducted. Results: A total of 6173 unique users were identified, of which 1822 (30%) were from the Netherlands, representing a total of 16,065 and 10,987 (68%) sessions, respectively. The median session duration per day was 01:47 min (IQR 0:51–03:03). The mobile application was mostly used on Monday, Tuesday, and Thursday, and the number of sessions was highest during the following time frames: 12–13 pm (9%), 17–18 pm (9%), and 13–14 pm (8%). Of 121 survey responses, most were medical doctors (47%), nurses (25%), or researchers (9%), working either in a teaching (40%), academic hospital (32%), or general hospital (19%). 83% of all respondents rated the application 4 or higher for satisfaction on a 5-point scale. Highest reported reasons of the use were urgent trial inquiry (57%) and usage during multi-disciplinary meetings (49%). Conclusion: The DCCG Trials application is frequently used, and the majority of users is highly satisfied. Relevance for Patients: Clustering trial information into one platform, such as DCCG trials app, has shown to be useful for medical professionals treating patients with colorectal carcinoma in the Netherlands.
Authors and Affiliations
Joost Huiskens, Michael S. Gałek-Aldridge, Jean-Michel Bakker, Pim B. Olthof1,3, Thomas M. van Gulik,Cornelis J. A. Punt, Martijn G. H. van Oijen
Keywords
Related Articles
- EP ID EP678753
- DOI -
- Views 224
- Downloads 0
Post-hepatectomy liver regeneration in the context of bile acid homeostasis and the gut-liver signaling axis
Background: Liver regeneration following partial hepatectomy (PHx) is a complicated process involving multiple organs and several types of signaling networks. The bile acid-activated metabolic pathways occupy an auxiliar...
Immune mechanisms of idiosyncratic drug-induced liver injury
Idiosyncratic drug reactions (IDRs) continue to be an important issue. Specifically, idiosyncratic drug-induced liver injury (IDILI) is the most likely IDR to lead to drug withdrawal, and it accounts for a significant po...
Racial and ethnic disparities in surgical amputations following serious musculoskeletal infections in a diverse New Mexico cohort
Background: Patients with serious musculoskeletal infections may encounter health disparities across multiple phases of prevention and treatment, including surgical intervention. The purpose of this study was to identify...
Connexin-based signaling and drug-induced hepatotoxicity
Being critical mediators of liver homeostasis, connexins and their channels are frequently involved in liver toxicity. In the current paper, specific attention is paid to actions of hepatotoxic drugs on these communicati...
Acellular porcine heart matrices: whole organ decellularization with 3D-bioscaffold & vascular preservation
Regenerative medicine, particularly decellularization-recellularization methods via whole-organ tissue engineering, has been increasingly studied due to the growing donor organ shortage. Though numerous decellularization...